Why you are still hungry on your GLP‑1

Introduction

You can still feel hungry while taking semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). Hunger alone does not tell you whether treatment is working. Review your appetite alongside your eating pattern, weight trend, and treatment goals with your prescriber.

Reduced hunger does not mean no hunger

In a 2021 randomized trial, researchers studied 72 adults with obesity for 20 weeks. Participants took weekly semaglutide injections, increasing to 2.4 mg, or placebo. The semaglutide group reported less hunger and ate 35% fewer calories at a test lunch than the placebo group. That was a group average at one meal, not a daily eating target or a promise that hunger would disappear. 1

Give your prescribed dose schedule time

For weekly Wegovy injections, the U.S. instructions start at a low dose and increase it over time to reduce stomach-related side effects. The starting dose is not the maintenance dose. Follow the instructions for your medication, and ask your prescriber before changing the amount or timing. 2

At follow-up, ask whether you are making progress toward your treatment goals and whether your current dose suits you. If weight loss has stopped, our GLP‑1 plateau guide explains what to review.

Review the pattern behind persistent hunger

Long gaps between meals can leave you hungry. The joint nutrition advisory recommends reviewing food intake, sleep, and stress during treatment. 3 Bring a few specific observations to your appointment:

• Meal timing: Record when you eat and whether hunger follows a long gap.
• Meal content: Note what you ate and whether you felt satisfied afterward.
• Daily context: Write down sleep, activity, stress, and when hunger interrupts your routine.
• Treatment history: Record missed doses, side effects, and any medication changes your clinician prescribed.

For example, “I skip lunch and feel hungry all evening” gives your clinician more to work with than “the medication isn’t working.” Our meal guide can help you plan meals to discuss with your dietitian.

Take sudden hunger with other symptoms seriously

Sudden hunger with sweating, shaking, or dizziness can indicate low blood sugar. Risk increases when semaglutide or tirzepatide is combined with insulin or a sulfonylurea. Check glucose if you can and follow your prescribed plan for low blood sugar; severe confusion or loss of consciousness needs emergency help. 2 4

Track appetite and meals with Shotsy

Keep appetite notes, meals, and injection history together in Shotsy. Bring the record to your appointment so you can explain when hunger occurs and what you have noticed.

Conclusion

Ask your prescriber for a review if hunger remains difficult to manage, even when you follow your treatment plan. Bring examples from your meals and symptoms so you can agree on the next step. If your concern is too little appetite, read our separate guide to eating when you are not hungry on a GLP‑1.